









Mercado
/
Acciones
/
nasdaq-gild
/

Gilead Sciences Inc

GILD

152.500USD

+3.130+2.10%

Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min

189.41BCap. mercado

23.42P/E TTM



Gilead Sciences Inc

152.500

+3.130+2.10%

Descripción general Finanzas Análisis Compañía

Descripción general

Finanzas

Análisis

Compañía

Más Datos de Gilead Sciences Inc Compañía

Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. It is focused on discovering, developing and delivering medicines to address unmet medical needs in virology, oncology and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Sacituzumab govitecan-hziy, and others. It also develops the HB-400 program and the HB-500 program. It develops therapies that are intended to provide functional cures for hepatitis B virus and human immunodeficiency virus-1. It operates in more than 35 countries worldwide.

Información de Gilead Sciences Inc



Símbolo de cotizaciónGILD

Nombre de la empresaGilead Sciences Inc

Fecha de salida a bolsaJan 22, 1992

Director ejecutivoO'Day (Daniel P)

Número de empleados17600

Tipo de seguridadOrdinary Share

Fin del año fiscalJan 22

Dirección333 Lakeside Dr

CiudadFOSTER CITY

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal94404-1147

Teléfono16505743000

Sitio Webhttps://www.gilead.com/

Símbolo de cotizaciónGILD

Fecha de salida a bolsaJan 22, 1992

Director ejecutivoO'Day (Daniel P)

Ejecutivos de Gilead Sciences Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Johanna Mercier

Chief Commercial Officer

76.00K

-3000.00%

Dr. Jacqueline K. Barton, Ph.D.

Independent Director

26.06K

+1516.00%

Mr. Anthony (Tony) Welters, J.D.

Lead Independent Director

11.75K

+1516.00%

Ms. Kelly A. Kramer

Independent Director

1.34K

Mr. Harish Manwani

Independent Director

Mr. Andrew D. (Andy) Dickinson

Chief Financial Officer

Mr. Daniel P. O'Day

Chairman of the Board, Chief Executive Officer

Dr. Sandra J. Horning, M.D.

Independent Director

Mr. Javier J. Rodriguez

Independent Director

Dr. Jeffrey A. (Jeff) Bluestone, Ph.D.

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Johanna Mercier

Chief Commercial Officer

76.00K

-3000.00%

Dr. Jacqueline K. Barton, Ph.D.

Independent Director

26.06K

+1516.00%

Mr. Anthony (Tony) Welters, J.D.

Lead Independent Director

11.75K

+1516.00%

Ms. Kelly A. Kramer

Independent Director

1.34K

Mr. Harish Manwani

Independent Director

Mr. Andrew D. (Andy) Dickinson

Chief Financial Officer

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

Por negocioUSD

Nombre

Ganancia

Proporción

Biktarvy

3.69B

47.46%

Descovy

698.00M

8.98%

Royalty Contract and other revenues

423.00M

5.44%

Genvoya

376.00M

4.84%

Trodelvy

357.00M

4.60%

Otro

2.23B

28.68%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

5.01B

64.45%

Europe

1.51B

19.47%

Other Locations

837.00M

10.77%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Biktarvy

3.69B

47.46%

Descovy

698.00M

8.98%

Royalty Contract and other revenues

423.00M

5.44%

Genvoya

376.00M

4.84%

Trodelvy

357.00M

4.60%

Otro

2.23B

28.68%

Estadísticas de accionistas

Actualizado: dom., 16 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

9.71%

BlackRock Institutional Trust Company, N.A.

5.86%

State Street Investment Management (US)

4.76%

Fidelity Management & Research Company LLC

4.34%

Capital World Investors

3.64%

Otro

71.69%

Accionistas

Proporción

The Vanguard Group, Inc.

9.71%

BlackRock Institutional Trust Company, N.A.

5.86%

State Street Investment Management (US)

4.76%

Fidelity Management & Research Company LLC

4.34%

Capital World Investors

3.64%

Otro

71.69%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

54.83%

Investment Advisor/Hedge Fund

25.90%

Research Firm

2.82%

Pension Fund

2.81%

Hedge Fund

2.00%

Bank and Trust

1.86%

Sovereign Wealth Fund

1.73%

Insurance Company

0.15%

Venture Capital

0.10%

Otro

7.80%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

3520

1.15B

92.30%

-4.70M

2025Q3

3433

1.13B

91.16%

+23.58K

2025Q2

3388

1.12B

90.01%

-12.02M

2025Q1

3442

1.12B

90.14%

-10.49M

2024Q4

3313

1.12B

90.13%

+4.63M

2024Q3

3207

1.10B

88.48%

-11.56M

2024Q2

3188

1.10B

88.24%

-14.37M

2024Q1

3196

1.10B

88.13%

-22.04M

2023Q4

3252

1.11B

88.75%

-8.79M

2023Q3

3190

1.10B

88.14%

-23.58M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

118.39M

9.54%

-392.37K

-0.33%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

72.73M

5.86%

+1.93M

+2.72%

Sep 30, 2025

State Street Investment Management (US)

59.09M

4.76%

-98.86K

-0.17%

Sep 30, 2025

Fidelity Management & Research Company LLC

53.80M

4.34%

+39.02K

+0.07%

Sep 30, 2025

Capital World Investors

45.18M

3.64%

-1.12M

-2.43%

Sep 30, 2025

Dodge & Cox

30.13M

2.43%

-685.19K

-2.22%

Sep 30, 2025

Capital Research Global Investors

30.01M

2.42%

-1.08M

-3.48%

Sep 30, 2025

Geode Capital Management, L.L.C.

29.93M

2.41%

+721.32K

+2.47%

Sep 30, 2025

Invesco Capital Management (QQQ Trust)

27.84M

2.24%

+1.83M

+7.02%

Dec 31, 2025

Wellington Management Company, LLP

25.62M

2.06%

-11.91M

-31.74%

Sep 30, 2025

ETFs relacionados



Actualizado: vie., 5 de dic

Nombre

Proporción

VanEck Biotech ETF

12.54%

ProShares Ultra Nasdaq Biotechnology

8.6%

Invesco Nasdaq Biotechnology ETF

8.54%

iShares Biotechnology ETF

7.24%

Simplify Health Care ETF

7.21%

Invesco Pharmaceuticals ETF

5.11%

Invesco Biotechnology & Genome ETF

5.08%

ProShares Nasdaq-100 Dorsey Wright Momentum ETF

4.62%

First Trust NASDAQ Pharmaceuticals ETF

4.12%

Tema Heart & Health ETF

3.95%

VanEck Biotech ETF

Proporción12.54%

ProShares Ultra Nasdaq Biotechnology

Proporción8.6%

Invesco Nasdaq Biotechnology ETF

Proporción8.54%

iShares Biotechnology ETF

Proporción7.24%

Simplify Health Care ETF

Proporción7.21%

Invesco Pharmaceuticals ETF

Proporción5.11%

Invesco Biotechnology & Genome ETF

Proporción5.08%

ProShares Nasdaq-100 Dorsey Wright Momentum ETF

Proporción4.62%

First Trust NASDAQ Pharmaceuticals ETF

Proporción4.12%

Tema Heart & Health ETF

Proporción3.95%

Dividendos



Un total de 15.04B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Oct 30, 2025

GILD.NB Final Cash Dividend of gross USD 0.79 paid on Dec 30, 2025 going ex on Dec 15, 2025

Dec 15, 2025

Dec 30, 2025

Dec 15, 2025

Aug 07, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Sep 29, 2025 going ex on Sep 15, 2025

Sep 15, 2025

Sep 29, 2025

Sep 15, 2025

Apr 24, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Jun 27, 2025 going ex on Jun 13, 2025

Jun 13, 2025

Jun 27, 2025

Jun 13, 2025

Feb 11, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Mar 28, 2025 going ex on Mar 14, 2025

Mar 14, 2025

Mar 28, 2025

Mar 14, 2025

Nov 12, 2024

GILD.NB Final Cash Dividend of gross USD 0.77 paid on Dec 30, 2024 going ex on Dec 13, 2024

Dec 13, 2024

Dec 30, 2024

Dec 13, 2024

Aug 13, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Sep 27, 2024 going ex on Sep 13, 2024

Sep 13, 2024

Sep 27, 2024

Sep 13, 2024

Apr 26, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Jun 27, 2024 going ex on Jun 14, 2024

Jun 14, 2024

Jun 27, 2024

Jun 14, 2024

Feb 06, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Mar 28, 2024 going ex on Mar 14, 2024

Mar 15, 2024

Mar 28, 2024

Mar 14, 2024

Nov 08, 2023

GILD.NB Final Cash Dividend of gross USD 0.75 paid on Dec 28, 2023 going ex on Dec 14, 2023

Dec 15, 2023

Dec 28, 2023

Dec 14, 2023

Aug 07, 2023

GILD.NB Interim Cash Dividend of gross USD 0.75 paid on Sep 28, 2023 going ex on Sep 14, 2023

Sep 15, 2023

Sep 28, 2023

Sep 14, 2023

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

